ClearBridge Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,303
Closed -$328K 1178
2019
Q3
$328K Sell
3,303
-1,146
-26% -$109K ﹤0.01% 715
2019
Q2
$411K Sell
4,449
-4,632
-51% -$440K ﹤0.01% 703
2019
Q1
$857K Sell
9,081
-6,989,507
-100% -$611M ﹤0.01% 686
2018
Q4
$449M Sell
6,998,588
-135,000
-2% -$9.97M 0.45% 65
2018
Q3
$638M Buy
7,133,588
+598,631
+9% +$52.9M 0.55% 44
2018
Q2
$519M Buy
6,534,957
+250,663
+4% +$20.8M 0.42% 70
2018
Q1
$561M Sell
6,284,294
-32,535
-0.5% -$3.12M 0.53% 49
2017
Q4
$659M Buy
6,316,829
+916,173
+17% +$103M 0.61% 39
2017
Q3
$788M Buy
5,400,656
+194,904
+4% +$26.5M 0.76% 27
2017
Q2
$676M Buy
5,205,752
+603,833
+13% +$74M 0.66% 33
2017
Q1
$573M Buy
4,601,919
+892,392
+24% +$107M 0.58% 41
2016
Q4
$429M Buy
3,709,527
+351,180
+10% +$39.1M 0.47% 62
2016
Q3
$351M Buy
3,358,347
+222,756
+7% +$24.1M 0.4% 74
2016
Q2
$309M Buy
3,135,591
+373,344
+14% +$38.6M 0.37% 79
2016
Q1
$276M Buy
2,762,247
+99,164
+4% +$10.2M 0.33% 84
2015
Q4
$319M Buy
2,663,083
+56,135
+2% +$6.49M 0.37% 76
2015
Q3
$282M Sell
2,606,948
-11,405
-0.4% -$1.42M 0.34% 85
2015
Q2
$303M Buy
2,618,353
+8,265
+0.3% +$945K 0.32% 88
2015
Q1
$301M Buy
2,610,088
+16,665
+0.6% +$1.99M 0.31% 91
2014
Q4
$290M Sell
2,593,423
-153,446
-6% -$16.2M 0.31% 96
2014
Q3
$260M Sell
2,746,869
-279,432
-9% -$25.2M 0.29% 101
2014
Q2
$260M Buy
3,026,301
+245,191
+9% +$18.6M 0.29% 105
2014
Q1
$194M Buy
2,781,110
+57,104
+2% +$4.52M 0.23% 120
2013
Q4
$230M Sell
2,724,006
-2,518
-0.1% -$199K 0.29% 105
2013
Q3
$210M Sell
2,726,524
-761,358
-22% -$53.4M 0.29% 111
2013
Q2
$204M Buy
+3,487,882
New +$210M 0.31% 100

Other funds holding CELG

ClearBridge Investments's CELG Position: Q4 2019 in Review

ClearBridge Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,303 shares — an estimated $328K sold.

ClearBridge Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $788M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • ClearBridge Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • ClearBridge Investments sold 3,303 Celgene Corp shares in Q4 2019, an estimated $328K.
  • ClearBridge Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • ClearBridge Investments's Celgene Corp position peaked at $788M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on ClearBridge Investments's 13F filing for Q4 2019, filed 14 Feb 2020.